Pravin Dugel - Sep 9, 2025 Form 4 Insider Report for OCULAR THERAPEUTIX, INC (OCUL)

Role
Executive Chairman, President and CEO, Director
Signature
/s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel
Stock symbol
OCUL
Transactions as of
Sep 9, 2025
Transactions value $
$0
Form type
4
Date filed
9/11/2025, 04:06 PM
Previous filing
Aug 27, 2025
Next filing
Nov 26, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dugel Pravin Executive Chairman, President and CEO, Director C/O OCULAR THERAPEUTIX, INC., 15 CROSBY DRIVE, BEDFORD /s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel 2025-09-11 0001700917

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUL Common Stock Gift $0 -49.8K -1.54% $0.00 3.18M Sep 9, 2025 Direct F1
transaction OCUL Common Stock Gift $0 +49.8K $0.00 49.8K Sep 9, 2025 By spouse F1
holding OCUL Common Stock 250K Sep 9, 2025 By Pravin Dugel 2024 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 9, 2025, the reporting person transferred 49,754 shares to his spouse for no consideration.

Remarks:

Executive Chairman, President and CEO